DEVIL, VAAD and vLSC constitute a spectrum of HPV-independent, p53-independent intra-epithelial neoplasia of the vulva.

HPV differentiated exophytic vulvar intra-epithelial lesion p53 vulvar acanthosis with altered differentiation vulvar intra-epithelial neoplasia verruciform vulvar lesion vulvar precursor lesion vulvar squamous cell carcinoma

Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 20 06 2021
accepted: 14 07 2021
pubmed: 16 7 2021
medline: 1 3 2022
entrez: 15 7 2021
Statut: ppublish

Résumé

We aimed to characterise a large cohort of non-invasive, human papillomavirus (HPV) and p53-independent verruciform lesions, such as 'vulvar acanthosis with altered differentiation' (VAAD), 'differentiated exophytic vulvar intra-epithelial lesion' (DEVIL) and 'verruciform lichen simplex chronicus' (vLSC). From January 2008 to December 2020 we retrospectively identified 36 eligible patients with verruciform non-invasive lesions (n = 36) and collected clinical, histological and follow-up parameters. Verruciform non-invasive lesions occurred at a median age of 71 years, with a median follow-up of 33.5 months. Clinically, pruritus was only reported in patients with VAAD (n = 3, 21%). Lesion colour was significantly different across categories (P = 0.028). Apart from the histopathological criteria already known to distinguish these entities (hypogranulosis, epithelial pallor and low-magnification architecture), no other significant criteria were discovered and significant overlap was observed, particularly between VAAD and DEVIL. Patients with vLSC trended towards longer survival without recurrence compared to VAAD and DEVIL (P = 0.082), but showed comparable invasion-free survival interval (P = 0.782). Squamous cell carcinomas (SCC) associated with either VAAD, DEVIL or vLSC displayed similar clinical, histopathological and biological parameters. In non-invasive precursor lesions, stromal oedema was associated with invasion (P = 0.015) and remained so upon Cox regression analysis (P = 0.009). Our study of HPV and p53 independent non-invasive verruciform lesions of the vulva highlights significant clinical, histopathological and biological overlap between VAAD, DEVIL and vLSC, suggesting that these pre-invasive lesions should be viewed as a spectrum. We also show that stromal features such as oedema might play an import role in progression to invasion.

Identifiants

pubmed: 34265101
doi: 10.1111/his.14451
doi:

Substances chimiques

TP53 protein, human 0
Tumor Suppressor Protein p53 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

975-988

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Singh N, Gilks CB. Vulval squamous cell carcinoma and its precursors. Histopathology 2020; 76; 128-138.
Nooij LS, Ter Haar NT, Ruano D et al. Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance. Clin. Cancer Res. 2017; 23; 6781-7679.
Nascimento AF, Granter SR, Cviko A et al. Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma? Am. J. Surg. Pathol. 2004; 28; 638-643.
Watkins JC, Howitt BE, Horowitz NS et al. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Mod. Pathol. 2017; 30; 448-458.
Watkins JC. Human papillomavirus-independent squamous lesions of the vulva. Surg. Pathol. Clin. 2019; 12; 249-261.
Tessier-Cloutier B, Kortekaas KE, Thompson E et al. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Mod. Pathol. 2020; 33; 1595-1605.
Heller DS, Day T, Allbritton JI et al. Diagnostic criteria for differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation. J. Low Genit. Tract. Dis. 2021; 25; 57-70.
Tessier-Cloutier B, Pors J, Thompson E et al. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. Mod. Pathol. 2021; 34; 508-518.
Akbari A, Pinto A, Amemiya Y et al. Differentiated exophytic vulvar intraepithelial lesion: clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva. Mod. Pathol. 2020; 33; 2011-2018.
Holthoff ER, Jeffus SK, Gehlot A et al. Perineural invasion is an independent pathologic indicator of recurrence in vulvar squamous cell carcinoma. Am. J. Surg. Pathol. 2015; 39; 1070-1074.
Holthoff ER, Spencer H, Kelly T et al. Pathologic features of aggressive vulvar carcinoma are associated with epithelial-mesenchymal transition. Hum. Pathol. 2016; 56; 22-30.
Jeffus SK, Gehlot A, Holthoff E et al. A fibromyxoid stromal response is associated with an infiltrative tumor morphology, perineural invasion, and lymph node metastasis in squamous cell carcinoma of the vulva. Am. J. Surg. Pathol. 2015; 39; 1226-1233.
Holthoff ER, Byrum SD, Mackintosh SG et al. Vulvar squamous cell carcinoma aggressiveness is associated with differential expression of collagen and STAT1. Clin. Proteom. 2017; 14; 40.

Auteurs

Simon F Roy (SF)

Département de Pathologie, Centre hospitalier de l'Université de Montréal, University of Montréal, Montréal, Canada.
Département de Pathologie et de Biologie Cellulaire, Université de Montréal, Montréal, Canada.

Jahg Wong (J)

Département de Pathologie, Centre hospitalier de l'Université de Montréal, University of Montréal, Montréal, Canada.
Département de Pathologie et de Biologie Cellulaire, Université de Montréal, Montréal, Canada.

Cécile Le Page (C)

Département de Pathologie, Centre hospitalier de l'Université de Montréal, University of Montréal, Montréal, Canada.

Danh Tran-Thanh (D)

Département de Pathologie, Centre hospitalier de l'Université de Montréal, University of Montréal, Montréal, Canada.

Maroie Barkati (M)

Département de Radio-oncologie, Centre hospitalier de l'Université de Montréal, Montréal, Canada.

Annick Pina (A)

Département d'Obstétrique et Gynécologie, Centre hospitalier de l'Université de Montréal, Montréal, Canada.

Vincent Quoc-Huy Trinh (VQ)

Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

Kurosh Rahimi (K)

Département de Pathologie, Centre hospitalier de l'Université de Montréal, University of Montréal, Montréal, Canada.
Département de Pathologie et de Biologie Cellulaire, Université de Montréal, Montréal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH